Alnylam’s second showing on this list is for its Sanofi-partnered siRNA therapy fitusiran, which the companies proposed for the treatment of hemophilia A and B. The FDA’s verdict is expected on March ...
South Africa's competition watchdog probes Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market South Africa’s competition watchdog is investigating ...
Novo Nordisk A/S and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human insulin pen market. South Africa’s Competition ...
March 4 (Reuters) - South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive practices in the human insulin pen market, the authority ...
Results from those studies in 2019 enabled the Sanofi and Regeneron antibody to become the first treatment approved by the FDA in inadequately controlled CRSwNP. Dupixent’s 52-week placebo ...
Four years after Sanofi shelled out $125 million for global rights to Biond Biologics’ novel immune checkpoint inhibitor, the French pharma is handing the prospect back to Biond. The move is due ...
The office of AmaZulu King Misuzulu kaZwelithini says the king will meet with the minister of land reform and rural development. The meeting is expected to discuss issues surrounding the governance of ...
Sanofi India share price gains were likely driven by its quarterly results performance and the dividend announcements, even though stock gave away most gains as the stock market crashed and Sensex ...
Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Shares of Sanofi India gained above 4 percent in early trade on February 28 following its Q4FY25 earnings, as the company reported healthy revenue growth even as profitability faced some ...
Sanofi India Ltd. (SIL) posted steady growth in the fourth quarter of 2024, with revenue increasing by 9.7% year-on-year (YoY) to ₹514.9 crore, compared to ₹469.2 crore in the corresponding quarter of ...
Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, appointments, order wins, and acquisitions, here’s a quick look at which ...